Interferon-α plus amantadine in chronic hepatitis C resistant to interferon alone: A pilot randomized study

Journal of Viral Hepatitis

Volumn 8, Issue 4, 2001, Pages 284-286

  Gaeta, G B ^a,b,c,d   Stornaiuolo, G ^a,b,c,d   Stanzione, M ^a,b,c,d   Ascione, T ^a,b,c,d   Pasquazzi, C ^a,b,c,d   Taliani, G ^a,b,c,d   Cimino, L ^a,b,c,d   Budillon, G ^a,b,c,d   Piccinino, F ^a,b,c,d  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Amantadine; Chronic hepatitis C; IFN resistant; Interferon

Indexed keywords

ALPHA INTERFERON; AMANTADINE; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HEPATITIS C; HUMAN; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

AMANTADINE; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; PILOT PROJECTS;

EID: 0034921253     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2001.00298.x     Document Type: Article

References (15)

1. Meta-analysis of interferon randomised trials in the treatment of viral hepatitis C: Effects of dose duration
2. Evaluation of efficacy of antiviral therapy for chronic hepatitis C: A EUROHEP Consensus Report on response criteria
3. Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C
4. Human leucocyte interferon alfa in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon alfa: A randomised controlled trial
5. EASL International Consensus Conference on Hepatitis C. Consensus Statement
6. Treatment of chronic hepatitis C with amantadine
7. Amantadine hydrochloride decreases serum ALT activity without effects on serum HCV-RNA in chronic hepatitis C patients
8. A pilot study of rimantadine for patients with chronic hepatitis C unresponsive to interferon therapy
9. Combination antiviral therapy for respiratory virus infections
10. Interferon alfa2b-ribavirin vs interferon alfa2b-amantadine combination in chronic hepatitis C. Analysis of a randomised double blind trial
11. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
12. Classification of chronic viral hepatitis: A need for reassessment
13. Ribavirin treatment for chronic hepatitis C
14. Hepatitis C viral dynamics in vivo and antiviral efficacy of interferon-α therapy
15. Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover